Pure Global
NCT06013410

Pathophysiological Effects of Persistently Colonized Microbiome on Irritable Bowel Syndrome

Second Affiliated Hospital, School of Medicine, Zhejiang University·ClinicalTrials.gov·diagnostic testRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Irritable Bowel Syndrome
Drug/Device/Intervention
colonoscopy
Study type
Interventional
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Location
Hangzhou, China
Timeline & enrollment
Phase
N/A
Start date
Aug 25, 2023
End date
May 15, 2026
Enrollment
30 participants
Primary outcome

mirobiome difference of the fecal between IBS and health controls,mirobiome difference of the fecal between IBS and health controls,Metabolic changes between IBS and Healthy controls

Summary

The goal of this clinical trial is to explore the pathophysiological effects of the
 persistently colonized microbiome in irritable bowel syndrome (IBS) patients. The main
 questions it aims to answer are:
 
 Question 1: the microbiome difference of the biofilm between IBS and healthy patients.
 
 Question 2: the metabolic product patterns between IBS and healthy patients.
 
 Participants will need to take a colonoscopy examination, two gut mucosal biopsy samples will
 be collected during the examination.
 
 Researchers will compare the IBS and healthy control groups to see if there was the
 disease-specific pattern in the microbiome and metabolic product of the biofilm.

ICD-10 classifications
Irritable bowel syndromeOther and unspecified irritable bowel syndromeIrritable bowel syndrome with mixed bowel habits [IBS-M]Irritable bowel syndrome with predominant constipation [IBS-C]Irritable bowel syndrome with predominant diarrhoea [IBS-D]
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06013410
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06013410 through Pure Global AI's free database. This phase not specified trial is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University and is currently Recruiting. The study focuses on Irritable Bowel Syndrome. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.